Persistence of HER2 overexpression on circulating tumor cells in patients after systemic treatment for HER2-positive breast cancer: Follow-up results of the German Success B trial von Neugebauer, Julia Katharina, Rack, Brigitte Kathrin, Jaeger, Bernadette Anna Sophia, Andergassen, Ulrich, Pestka, Aurelia, Fasching, Peter A., Friedl, Thomas W. P., Mouarrawy, Doraid, Clemens, Michael R., Ziemendorff, Gabriele, Heinrich, Georg, von Abel, Ekkehard, Schneeweiss, Andreas, Beckmann, Matthias W., Pantel, Klaus, Janni, Wolfgang

Volltext

HER2 expression on circulating tumor cells (CTC) in patients with early HER2-positive breast cancer: Results of the German SUCCESS B trial von Jaeger, Bernadette Anna Sophia, Rack, Brigitte Kathrin, Neugebauer, Julia Katharina, Andergassen, Ulrich, Melcher, Carola Anna, Mouarrawy, Doraid, Ziemendorff, Gabriele, Clemens, Michael, von Abel, Ekkehard, Heinrich, Georg, Schueller, Katharina, Schneeweiss, Andreas, Lichtenegger, Werner, Beckmann, Matthias W., Pantel, Klaus, Sommer, Harald Leo, Friese, Klaus, Janni, Wolfgang

Volltext